Key result
Admission NT-proBNP predicts unfavorable 90-day functional outcomes in ischemic stroke, though NIHSS offers superior accuracy.
Why the study?
Does admission NT-proBNP predict stroke severity and 90-day functional outcome in patients with acute ischaemic stroke?
Cohort (n=90)
No
Does admission NT-proBNP predict stroke severity and 90-day functional outcome in patients with acute ischaemic stroke?
Admission NT-proBNP is significantly associated with stroke severity and 90-day functional outcomes in acute ischaemic stroke, serving as a potential adjunct biomarker for prognostication.
Answers are grounded in this paper and cite their sources.
May aid acute ischaemic stroke prognostication; hypothesis-generating and requires prospective validation before clinical use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Vallisree et al. (2026) conducted a cohort in Acute Ischaemic Stroke (n=90). Admission NT-proBNP was evaluated on Unfavourable functional outcome at 90 days (OR 1.00, 95% CI 1.00-1.01, p=0.049). Admission NT-proBNP was an independent predictor of unfavourable 90-day functional outcome in acute ischaemic stroke, though NIHSS had superior accuracy.
Synapse has enriched 10 related papers. Consider them for comparative context: